Promoting Global Cardiovascular Health: Moving Forward

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Circulation

• Publication date

  2011-04-19

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.110.009522PMID 21502585
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The United States President's Emergency Plan for AIDS Relief: A Story of Partnerships and Smart Investments to Turn the Tide of the Global AIDS Pandemic

  2012cited by this paper
• Plant-made vaccines in support of the Millennium Development Goals

  2011cited by this paper
• The Bill & Melinda Gates Foundation's grant-making programme for global health

  2011cited by this paper
• Prices of antihypertensive medicines in sub‐Saharan Africa and alignment to WHO’s model list of essential medicines

  2010cited by this paper
• The Economic Implications of Non-Communicable Disease for India

  2010cited by this paper
• Assessment of the impact of market regulation in Mali on the price of essential medicines provided through the private sector.

  2010cited by this paper
• Where Have All the Donors Gone? Scarce Donor Funding for Non-Communicable Diseases

  2010cited by this paper
• Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing World

  2010cited by this paper
• Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health

  2010cited by this paper
• Growing epidemic of coronary heart disease in low- and middle-income countries.

  2010cited by this paper
• Use of mass media campaigns to change health behaviour.

  2010cited by this paper
• Reducing population salt intake worldwide: from evidence to implementation.

  2010cited by this paper
• The Bill & Melinda Gates Foundation's grant-making programme for global health.

  2009cited by this paper
• Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.

  2009cited by this paper
• Issues to consider in the pharmaceutical development of a cardiovascular polypill

  2009cited by this paper
• Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases.

  2009cited by this paper
• Medicines coverage and community-based health insurance in low-income countries

  2008cited by this paper
• Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa

  2008cited by this paper
• The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.

  2007cited by this paper
• Essential Medicines for the Whole World

  2007cited by this paper
• The burden and costs of chronic diseases in low-income and middle-income countries.

  2007cited by this paper
• Prices & availability of common medicines at six sites in India using a standard methodology.

  2007cited by this paper
• The 10-year struggle to provide antiretroviral treatment to people with HIV in the developing world.

  2006cited by this paper
• Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis.

  2006cited by this paper
• Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective.

  2004cited by this paper
• South Africa: Treatment Action Campaign steps up pressure.

  2003cited by this paper
• The world health report 2002 - reducing risks, promoting healthy life.

  2003cited by this paper
• A strategy to reduce cardiovascular disease by more than 80%

  2003cited by this paper
• IMPLICATIONS OF THE DOHA DECLARATION ON THE TRIPS AGREEMENT AND PUBLIC HEALTH

  2002cited by this paper
• The pharmaceutical industry as a medicines provider.

  2002cited by this paper
• Twenty-five years of essential medicines.

  2002cited by this paper
• THE WORLD HEALTH ORGANIZATION

  1954cited by this paper

• Investigating the risk factors of sleep disturbances following percutaneous coronary intervention in patients with coronary artery disease: a case-control study

  2026cites this paper
• Polymorphic and Expressional Analysis of Genes CDKN2B and ADIPOQ in Cardiovascular Patients Using Conventional and qPCR Approach

  2025influential citation
• A Real-Time Wrist Action Reconstruction System Design Based on BP Neural Network Model to Predict Multiple FES Parameters

  2025cites this paper
• Cardiovascular Disease Training Programmes: Three Schemes to Train Leaders for Future Challenges

  2024cites this paper
• Anti-Motion Interference Electrocardiograph Monitoring System: A Review

  2024cites this paper
• Assessment the awareness toward hypertension and diabetes mellitus: Syrian cross sectional study

  2023cites this paper
• Access to cardiovascular medicines in low- and middle-income countries: a mini review

  2023cites this paper
• Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies

  2023cites this paper
• Community Mapping And Health Seeking Practices Among Residents of an Indonesian Village

  2023cites this paper
• Epidemiology of Type-II Diabetes and its Risk Factors in Punjab, Pakistan: A Retrospective Study

  2023cites this paper
• Novel Electrochemiluminescent Immunosensor Using Dual Amplified Signals from a CoFe Prussian Blue Analogue and Au Nanoparticle for the Detection of Lp-PLA2.

  2023cites this paper
• A 30-year trend of ischemic heart disease burden in a developing country; a systematic analysis of the global burden of disease study 2019 in Iran.

  2023cites this paper
• Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events

  2022cites this paper
• The magnitude of type 2 diabetes mellitus and cardiovascular disease risk factors among young adults in urban settings: a cross-sectional survey in Mwanza, Tanzania

  2022cites this paper
• Verification of the folkloric and anecdotal antidiabetic effects of Hypoxis hemerocallidea (Fisch., C.A. Mey. & Avé-Lall) and isolated, β-sitosterol using early-stage type II spontaneous diabetic mutant BKS-Leprdb mice

  2022cites this paper
• Screening and Interventions for Cardiovascular Disease Prevention in the Limpopo Province, South Africa: Use of the Community Action Model

  2022cites this paper
• Do Non-Communicable Diseases Influence Sustainable Development in Sub-Saharan Africa? A Panel Autoregressive Distributive Lag (ARDL) Model.

  2021cites this paper
• Effect of community-based lifestyle education intervention to reduce cardiovascular diseases risk factors among vulnerable population in Dodoma city, Tanzania: a cluster randomized controlled trial study protocol

  2021cites this paper
• Improving R Peak Detection in ECG Signal Using Dynamic Mode Selected Energy and Adaptive Window Sizing Algorithm with Decision Tree Algorithm

  2021cites this paper
• Dose of Cardiac Rehabilitation to Reduce Mortality and Morbidity: A Population‐Based Study

  2021cites this paper
• Community-Based Screening for Cardiovascular Disease in the Capricorn District of Limpopo Province, South Africa

  2021cites this paper
• Sleep profile and the risk of cardiovascular events in patients undergoing percutaneous coronary intervention

  2021cites this paper
• Cascades of diabetes and hypertension care in Samoa: Identifying gaps in the diagnosis, treatment, and control continuum – a cross-sectional study

  2021cites this paper
• Flexible silver nanowire dry electrodes for long-term electrocardiographic monitoring

  2021cites this paper
• Cardiovascular disease (CVD): assessment, prediction and policy implications

  2021cites this paper
• The effect of walnut consumption on cardiometabolic profiles of individuals with abnormal glucose homoeostasis: a systematic review and meta-analysis of clinical trials

  2021cites this paper
• Streamlining drug discovery assays for cardiovascular disease using zebrafish

  2020cites this paper
• Vapor-Deposited Nanocoatings for Sustained Zero-Order Release of Antiproliferative Drugs.

  2020cites this paper
• Cardiovascular risk assessment in the resource limited setting of Western Honduras: An epidemiological perspective

  2020cites this paper
• Novel Point Mutations in Mitochondrial MT-CO2 Gene May Be Risk Factors for Coronary Artery Disease

  2020cites this paper
• An Internet-Based Intervention for Cardiovascular Disease Management Integrated With Primary Care Electronic Health Records: Mixed Methods Evaluation of Implementation Fidelity and User Engagement

  2020cites this paper
• Monoterpenes and their derivatives as agents for cardiovascular disease management: A systematic review and meta-analysis.

  2020cites this paper
• MANUFACTURING AND POSITIONING (GENERATIONS) OF OIL‐IN‐WATER NANOSIZED EMULSIONS

  2020cites this paper
• Je možné zlepšiť primárnu prevenciu ischemickej

  2020cites this paper
• Exposure of mobile phones and mass media in maternal health services use in developing nations: evidence from Urban Health Survey 2013 of Bangladesh

  2020cites this paper
• Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.

  2020cites this paper
• Assess the quality of sleep among patient with myocardial infarction

  2019cites this paper
• Magnitude of Type 2 Diabetes Mellitus, Dyslipidemia and Hypertension Among Young Adults in Urban Settings: A Cross Sectional Survey in Mwanza, Tanzania

  2019cites this paper
• High-Throughput in Vivo Screening for Cardiovascular Drug

  2019cites this paper
• Welfare and Redistributive Effects of Social Assistance in the Global South

  2019cites this paper
• A Hybrid Risk Assessment Model for Cardiovascular Disease Using Cox Regression Analysis and a 2-means clustering algorithm

  2019cites this paper
• Current Research Trends in Traditional Chinese Medicine Formula: A Bibliometric Review from 2000 to 2016

  2019cites this paper
• Role Of Malnutrition Towards Predisposing The Population Towards Non-Communicable Diseases (Ncds)

  2019cites this paper
• Coexistence effect of hypertension and angiotensin II on the risk of coronary heart disease: a population-based prospective cohort study among Inner Mongolians in China

  2019cites this paper
• A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.

  2019cites this paper
• Integrated management of HIV/NCDs: knowledge, attitudes, and practices of health care workers in Gaborone, Botswana

  2019cites this paper
• Screening drugs for myocardial disease in vivo with zebrafish: an expert update

  2019cites this paper
• Using path analysis to investigate the relationships between depression, anxiety, and health-related quality of life among patients with coronary artery disease

  2019cites this paper
• The Global Health Classroom: Collaborative Global Health Learning between New Zealand and Samoan Medical Students in a Virtual Classroom

  2018cites this paper
• Effectiveness, acceptability and usefulness of mobile applications for cardiovascular disease self-management: Systematic review with meta-synthesis of quantitative and qualitative data

  2018cites this paper
• Effect of training community health workers and their interventions on cardiovascular disease risk factors among adults in Morogoro, Tanzania: study protocol for a cluster randomized controlled trial

  2018cites this paper
• Prevalence of the cardiovascular health status in adults: A systematic review and meta-analysis.

  2018cites this paper
• Sleep Quality, Sleep Duration, and the Risk of Coronary Heart Disease: A Prospective Cohort Study With 60,586 Adults

  2018cites this paper
• Satisfaction about Patient-centeredness and Healthcare System among Patients with Chronic Multimorbidity

  2018cites this paper
• Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.

  2017cites this paper
• Prevalence of Cardiovascular risk factors among the residents of urban community of Kathmandu municipality

  2017cites this paper
• Dietary intake and prospective changes in cardiometabolic risk factors in children and youth.

  2017cites this paper
• Functional roles of exosomes in cardiovascular disorders: a systematic review.

  2017cites this paper
• DNA Methylation in NFATC1 Gene Promoter is Related to Longevity in Chinese Population

  2017cites this paper
• Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease

  2017cites this paper
• Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis.

  2017cites this paper
• Prevention of Non-communicable Diseases by Balanced Nutrition: Population- specific Effective Public Health Approaches in Developing Countries.

  2017cites this paper
• Functional roles of exosomes in cardiovascular disorders : a systematic review

  2017cites this paper
• Multifunctional nanosized emulsions for theragnosis of life threatening diseases

  2017cites this paper
• Secondary cvd prevention-Lipid modification strategies: A critical analysis.

  2017cites this paper
• Mutation Analysis of the Mitochondrial tRNA Genes in Iranian Coronary Atherosclerosis Patients

  2017cites this paper
• Prevalence of Risk Factors for Non-communicable Diseases in a Rural Setting of Dhaka , Bangladesh

  2017cites this paper
• Prediabetes and metabolic syndrome in Nigerian adults : prevalence and risk screening

  2016cites this paper
• Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases.

  2016cites this paper
• Prevalence and prevention of cardiovascular disease and diabetes mellitus.

  2016cites this paper
• Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?

  2016cites this paper
• Family-Based Approaches to Cardiovascular Health Promotion.

  2016cites this paper
• Preexisting Heart Disease Underlies Newly Diagnosed Atrial Fibrillation After Acute Ischemic Stroke

  2016cites this paper
• Dietary Nitrate, Nitric Oxide, and Cardiovascular Health

  2016cites this paper
• Disheartening Disparities.

  2016cites this paper
• Top 100 cited articles in cardiovascular magnetic resonance: a bibliometric analysis

  2016cites this paper
• Risk assessment in the prevention of cardiovascular disease in low-resource settings.

  2016cites this paper
• Wide Variation in Absolute Cardiovascular Risk Assessment in Aboriginal and Torres Strait Islander People with Type 2 Diabetes

  2016cites this paper
• A Model of Noncommunicable Diseases Determinants in Iran; a Qualitative Study

  2016cites this paper
• Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet?

  2016cites this paper
• Adherence to Treatment in Hypertension.

  2016cites this paper
• Isquemia miocárdica: conceptos básicos, diagnóstico e implicaciones clínicas. Segunda parte

  2016cites this paper
• Therapeutic physical culture in the treatment of chronic non-communicable diseases: medicine based on physical culture

  2015cites this paper
• Effects of Long-Term Statin Therapy in Coronary Artery Disease Patients with or without Chronic Kidney Disease

  2015cites this paper
• Moving Toward Global Primordial Prevention in Cardiovascular Disease: The Heart of the Matter.

  2015cites this paper
• Cardiovascular drug development: is it dead or just hibernating?

  2015cites this paper
• Next Steps in Primary Prevention of Coronary Heart Disease: Rationale for and Design of the ECAD Trial.

  2015cites this paper
• Health Care in Transition: Primary Prevention and Health Disparities in Focus.

  2015cites this paper
• The association of inflammatory biomarkers with cardiovascular events : a long and winding path

  2015cites this paper
• Avaluació d'una intervenció comunitària en salut cardiovascular segons el model salutogènic

  2015cites this paper
• La cultura física terapéutica en el tratamiento de las enfermedades crónicas no transmisibles: medicina basada en la cultura física

  2015cites this paper
• Characterisation of microparticles and nitro-oxidative stress in cardiometabolic disease

  2015cites this paper
• Social Mobilization for Cardiovascular Disease Prevention and Control

  2015cites this paper
• Evaluation of Aspirin Use for Primary and Secondary Prevention of Cardiovascular Diseases among Lebanese Population

  2015cites this paper
• Global burden of cardiovascular disease: time to implement feasible strategies and to monitor results.

  2014cites this paper
• Perceptions and Practices of Cardiovascular Health: A Population Perspective from a Peri-Urban Nepalese Community

  2014cites this paper
• Global Perspective on Acute Coronary Syndrome: A Burden on the Young and Poor

  2014cites this paper
• Cardiovascular Disease Risk Prevention: Preliminary Survey of Baseline Knowledge, Attitude and Practices of a Nigerian Rural Community

  2014cites this paper
• Influence and Predicting Variables of Obstructive Sleep Apnea on Cardiac Function and Remodeling in Patients without Congestive Heart Failure

  2014cites this paper
• Non‐Communicable Diseases (NCDs) in developing countries: a symposium report

  2014cites this paper